0 Ratings
ID

35809

Description

Study ID: 102370 (primary study) Clinical Study ID: 102370 Study Title: A multicentre when given according to the 2-4-6 month schedule to healthy infants with booster dose at 12 to 15 months Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00134719 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Haemophilus influenzae Type b, Meningococcal C and Y-Tetanus Toxoid Conjugate Vaccine Trade Name: BIO HIB-MENCY-TT; MenHibrix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis

Keywords

Versions (1)
  1. 3/25/19 3/25/19 -
Copyright Holder

GlaxoSmithKline

Uploaded on

March 25, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    GSK Biologicals' Hib-MenCY-TT Conjugate Vaccine vs ActHIB® & MenC Conjugate Licensed Vaccine (NCT00134719)

    English

    Medication

    1 forms  
    1. StudyEvent: ODM
      1. Medication
    Administrative Data
    Description

    Administrative Data

    Subject Number
    Description

    Clinical Trial Subject Unique Identifier

    Data type

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Medication
    Description

    Medication

    Alias
    UMLS CUI-1
    C0013227
    Have any medications/treatments been administered since the start of the booster phase ?
    Description

    Pharmaceutical Preparation, Accelerated Phase

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0087111
    UMLS CUI [1,3]
    C0457345
    Trade / Generic Name
    Description

    Pharmaceutical Preparations, Medication name

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C2360065
    Medical Indication
    Description

    Pharmaceutical Preparations, Indication

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C3146298
    Total daily dose
    Description

    Pharmaceutical Preparations, Daily Dose, Total

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C2348070
    UMLS CUI [1,3]
    C0439810
    Route
    Description

    Pharmaceutical Preparations, Drug Administration Routes

    Data type

    text

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0013153
    Start Date
    Description

    Pharmaceutical Preparations, Start Date

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0808070
    End Date
    Description

    Pharmaceutical Preparations, End Date

    Data type

    date

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0806020
    Tick box if continuing at end of study
    Description

    Pharmaceutical Preparations, Continuous

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0013227
    UMLS CUI [1,2]
    C0549178
    Back to the top of the page

    Similar models

    Medication

    1 forms
    1. StudyEvent: ODM
      1. Medication
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Administrative Data
    Clinical Trial Subject Unique Identifier
    Item
    Subject Number
    integer
    C2348585 (UMLS CUI [1])
    Item Group
    Medication
    C0013227 (UMLS CUI-1)
    Pharmaceutical Preparation, Accelerated Phase
    Item
    Have any medications/treatments been administered since the start of the booster phase ?
    boolean
    C0013227 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    C0457345 (UMLS CUI [1,3])
    Pharmaceutical Preparations, Medication name
    Item
    Trade / Generic Name
    text
    C0013227 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    Item
    Medical Indication
    text
    C0013227 (UMLS CUI [1,1])
    C3146298 (UMLS CUI [1,2])
    Pharmaceutical Preparations, Indication
    Code List
    Medical Indication
    CL Item
    Prophylactic (Prophylactic)
    Item
    Total daily dose
    text
    C0013227 (UMLS CUI [1,1])
    C2348070 (UMLS CUI [1,2])
    C0439810 (UMLS CUI [1,3])
    Pharmaceutical Preparations, Indication
    Code List
    Total daily dose
    Pharmaceutical Preparations, Drug Administration Routes
    Item
    Route
    text
    C0013227 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Pharmaceutical Preparations, Start Date
    Item
    Start Date
    date
    C0013227 (UMLS CUI [1,1])
    C0808070 (UMLS CUI [1,2])
    Pharmaceutical Preparations, End Date
    Item
    End Date
    date
    C0013227 (UMLS CUI [1,1])
    C0806020 (UMLS CUI [1,2])
    Pharmaceutical Preparations, Continuous
    Item
    Tick box if continuing at end of study
    boolean
    C0013227 (UMLS CUI [1,1])
    C0549178 (UMLS CUI [1,2])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial